Oramed Pharmaceuticals
ORMP
#9090
Rank
โ‚ฌ0.10 B
Marketcap
2,58ย โ‚ฌ
Share price
4.66%
Change (1 day)
10.65%
Change (1 year)

Earnings for Oramed Pharmaceuticals (ORMP)

Earnings in 2025 (TTM): -โ‚ฌ5.2 Million

According to Oramed Pharmaceuticals's latest financial reports the company's current earnings are โ‚ฌ2 Million. In 2024 the company made an earning of โ‚ฌ0.3 Million a decrease over its 2023 earnings that were of โ‚ฌ6.06 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Oramed Pharmaceuticals from 2006 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -โ‚ฌ5.2 Million-1827.22%
2024 โ‚ฌ0.3 M-95.05%
2023 โ‚ฌ6.06 M-119.45%
2022 -โ‚ฌ31.19 Million39.17%
2021 -โ‚ฌ22.42 Million73.93%
2020 -โ‚ฌ12.89 Million18.53%
2019 -โ‚ฌ10.88 Million-16.62%
2018 -โ‚ฌ13.04 Million38.32%
2017 -โ‚ฌ9.43 Million12.51%
2016 -โ‚ฌ8.38 Million25.01%
2015 -โ‚ฌ6.71 Million18.18%
2014 -โ‚ฌ5.68 Million39.72%
2013 -โ‚ฌ4.06 Million46.4%
2012 -โ‚ฌ2.78 Million128.32%
2011 -โ‚ฌ1.22 Million-51.47%
2010 -โ‚ฌ2.51 Million35.21%
2009 -โ‚ฌ1.86 Million
2007 -โ‚ฌ2.91 Million607.04%
2006 -โ‚ฌ0.42 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Ultragenyx Pharmaceutical
RARE
-โ‚ฌ0.45 Billion 12,138.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Novo Nordisk
NVO
โ‚ฌ17.75 B-491,978.24%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
Sanofi
SNY
โ‚ฌ7.74 B-214,830.06%๐Ÿ‡ซ๐Ÿ‡ท France
Compugen
CGEN
-โ‚ฌ23.47 Million 550.33%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Lexicon Pharmaceuticals
LXRX
-โ‚ฌ58.4 Million 1,518.17%๐Ÿ‡บ๐Ÿ‡ธ USA